Skip to main content
Max Financial Services Limited logo

Max Financial Services Limited — Investor Relations & Filings

Ticker · MFSL ISIN · INE180A01020 LEI · 335800Y9FX8XGFB64S40 BSE.NS Financial and insurance activities
Open in API
Filings indexed 2,321 across all filing types
Latest filing 2023-03-18 Regulatory Filings
Country IN India
Listing BSE.NS MFSL

About Max Financial Services Limited

https://maxfinancialservices.com/

Max Financial Services Limited (MFSL) serves as the holding company for Max Life Insurance Company Limited, representing the Max Group's interests in the life insurance sector. The company focuses on providing a comprehensive suite of life insurance products, including protection, savings, investment, and retirement solutions. Through its subsidiary, it operates a multi-channel distribution network comprising agency forces, bancassurance partnerships—notably with Axis Bank—and digital platforms. MFSL emphasizes long-term value creation through customer-centric product innovation, robust risk management, and technological integration. The organization aims to enhance financial security for its diverse client base by offering tailored insurance plans and maintaining high claims settlement ratios. Its strategic focus remains on expanding market presence and driving operational efficiencies within the life insurance domain.

Recent filings

Filing Released Lang Actions
This is with reference to our earlier letter dated February 15, 2023, informing Stock Exchanges for seeking approval of the members by way of Special Resolution through Postal Ballot for ....
Regulatory Filings
2023-03-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing a schedule of analyst and institutional investor meetings. It explicitly states that no unpublished price sensitive information will be discussed and refers to an already available Investor Presentation on the company's website. The document is short (2043 characters) and serves as an announcement of meetings and availability of the presentation rather than the presentation itself. Therefore, it is not the Investor Presentation (IP) itself but an announcement related to investor communications. Given the nature and length, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure under SEBI regulations, rather than a detailed report or presentation.
2023-03-17 English
As per the details attached
Investor Presentation Classification · 90% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing a schedule of analyst and institutional investor meetings. It explicitly states that no unpublished price sensitive information will be discussed and refers to an Investor Presentation already available on the company's website. The document is short (2043 characters) and serves as an announcement of meetings and the availability of an investor presentation rather than containing the presentation itself or detailed financial data. Therefore, it is best classified as an Investor Presentation announcement or related disclosure. Given the options, the closest and most appropriate classification is 'Investor Presentation' (IP).
2023-03-17 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about share certificate loss notifications and does not contain financial results, management discussion, voting results, or any other report type. It is a regulatory disclosure related to shareholding records but not a major shareholding notification or director dealing. Given the nature and content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-06 English
As per the disclosure attached
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about share certificate loss and replacement, not about financial results, management changes, or other report types. It is a regulatory disclosure related to shareholding but does not report changes in major shareholding levels or insider transactions. It is not a report or announcement of financial performance or governance changes. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-06 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, informing about a review conducted by Willis Towers Watson Actuarial Advisory LLP on the embedded value results of Max Life Insurance Company Limited as at 31 December 2022 and the value of new business during 1 April 2022 to 31 December 2022. The document includes the opinion letter from WTW confirming the methodology and assumptions comply with actuarial standards and that no material issues were found. The document is a regulatory disclosure about an actuarial review and opinion, not a full annual or interim report, nor an earnings release or management discussion. It is a formal regulatory announcement of a review opinion, which fits best under Regulatory Filings (RNS) as it does not contain comprehensive financial statements or detailed management analysis. The document length is 4346 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2023-03-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.